MétaCan
Menu
Back to cohort

Cumulative incidence estimates for solid tumors after HCT in the CIBMTR and California Cancer Registry

2024· article· en· W4399566448 on OpenAlexfundno aff
Sara J. Schonfeld, Bryan Valcárcel, Christa L. Meyer, Bronwen E. Shaw, Rachel Phelan, J. Douglas Rizzo, Ann Brunson, Julianne J.P. Cooley, Renata Abrahão, Ted Wun, Shahinaz M. Gadalla, Eric A. Engels, Paul S. Albert, Rafeek A. Yusuf, Stephen R. Spellman, Rochelle E. Curtis, Jeffery J. Auletta, Lori Muffly, Theresa H.M. Keegan, Lindsay M. Morton

Bibliographic record

VenueBlood Advances · 2024
Typearticle
Languageen
FieldMedicine
TopicAcute Lymphoblastic Leukemia research
Canadian institutionsnot available
FundersNational Institute of Allergy and Infectious DiseasesOffice of Naval ResearchNational Center for Chronic Disease Prevention and Health PromotionNational Heart, Lung, and Blood InstituteLegend BiotechPharmacyclicsTakeda OncologyHealth Resources and Services AdministrationSeagenKiadis Pharmabluebird bioMedacJazz PharmaceuticalsBeiGeneNational Center for Advancing Translational SciencesHistoGeneticsSwedish Orphan BiovitrumOmeros CorporationVertex PharmaceuticalsAlexion PharmaceuticalsMallinckrodt PharmaceuticalsAstellas Pharma USUniversity of Southern CaliforniaAtara BiotherapeuticsCareDxActinium PharmaceuticalsNational Cancer InstituteGilead SciencesAstellas PharmaAdaptive BiotechnologiesMorphoSysCalifornia Department of Public HealthSanofiGlaxoSmithKlineCSL BehringBristol-Myers SquibbAstraZenecaCenters for Disease Control and PreventionGateway for Cancer ResearchAmgenIncytePfizer
KeywordsCumulative incidencePopulationMedicineIncidence (geometry)CohortCancer registryTransplantationHematopoietic cellOncologyDemographyInternal medicineEnvironmental healthBiologyMathematicsHaematopoiesis

Abstract

fetched live from OpenAlex

ABSTRACT: Compared with the general population, hematopoietic cell transplantation (HCT) survivors are at elevated risk for developing solid subsequent neoplasms (SNs). The Center for International Blood and Marrow Transplant Research (CIBMTR) is a key resource for quantifying solid SN incidence following HCT, but the completeness of SN ascertainment is uncertain. Within a cohort of 18 450 CIBMTR patients linked to the California Cancer Registry (CCR), we evaluated the completeness of solid SN data reported to the CIBMTR from 1991 to 2018 to understand the implications of using CIBMTR data alone or combined with CCR data to quantify the burden of solid SNs after HCT. We estimated the cumulative incidence of developing a solid SN, accounting for the competing risk of death. Within the cohort, solid SNs were reported among 724 patients; 15.6% of these patients had an SN reported by CIBMTR only, 36.9% by CCR only, and 47.5% by both. The corresponding cumulative incidence of developing a solid SN at 10 years following a first HCT was 4.0% (95% confidence interval [CI], 3.5-4.4) according to CIBMTR data only, 5.3% (95% CI, 4.9-5.9) according to CCR data only, and 6.3% (95% CI, 5.7-6.8) according to both sources combined. The patterns were similar for allogeneic and autologous HCT recipients. Linking detailed HCT information from CIBMTR with comprehensive SN data from cancer registries provides an opportunity to optimize SN ascertainment for informing follow-up care practices and evaluating risk factors in the growing population of HCT survivors.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.431
Threshold uncertainty score0.355

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.357
Teacher spread0.341 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueBlood AdvancesSame topicAcute Lymphoblastic Leukemia researchFrench-language works237,207